NCT00840281View on ClinicalTrials.gov

Cefprozil 500 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

Cefzil® 500 mg tablets

1 x 500 mg, single-dose fasting

DRUG

Cefprozil 500 mg Tablets

1 x 500 mg, single-dose fasting

Trial Locations (1)

63301

Gateway Medical Research, Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840281 - Cefprozil 500 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter